(E)-thiamethoxam decreases expression ISO RGD:735444 6480464 Thiamethoxam results in decreased expression of PLCG2 mRNA CTD PMID:33533595 1,2-dimethylhydrazine increases expression ISO RGD:735444 6480464 1, 2-Dimethylhydrazine results in increased expression of PLCG2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:735444 6480464 Ethinyl Estradiol results in increased expression of PLCG2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:735444 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLCG2 mRNA CTD PMID:17942748 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:732989 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735444 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLCG2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLCG2 mRNA CTD PMID:32109520 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735444 6480464 Tetrachlorodibenzodioxin affects the expression of PLCG2 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735444 6480464 Tetrachlorodibenzodioxin results in increased expression of PLCG2 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PLCG2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:735444 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLCG2 mRNA CTD PMID:20159946 2-butoxyethanol decreases expression ISO RGD:735444 6480464 n-butoxyethanol results in decreased expression of PLCG2 mRNA CTD PMID:19812364 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:732989 6480464 tetrabromobisphenol A results in decreased expression of PLCG2 protein CTD PMID:31675489 3-methylcholanthrene multiple interactions ISO RGD:735444 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PLCG2 mRNA CTD PMID:23519560 5-aza-2'-deoxycytidine affects expression ISO RGD:732989 6480464 Decitabine affects the expression of PLCG2 mRNA CTD PMID:23300844 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PLCG2 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of PLCG2 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:732989 6480464 Aflatoxin B1 affects the expression of PLCG2 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:732989 6480464 Aflatoxin B1 results in increased methylation of PLCG2 exon CTD PMID:30157460 aflatoxin B1 decreases methylation ISO RGD:732989 6480464 Aflatoxin B1 results in decreased methylation of PLCG2 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:732989 6480464 Aflatoxin B1 results in decreased expression of PLCG2 mRNA CTD PMID:22100608 , PMID:27153756 Aflatoxin B2 alpha increases methylation ISO RGD:732989 6480464 aflatoxin B2 results in increased methylation of PLCG2 exon, aflatoxin B2 results in increased methylation of PLCG2 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:732989 6480464 Tretinoin results in increased expression of PLCG2 mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PLCG2 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of PLCG2 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO RGD:732989 6480464 aristolochic acid I results in decreased expression of PLCG2 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:732989 6480464 arsenite inhibits the reaction [G3BP1 protein binds to PLCG2 mRNA] CTD PMID:32406909 arsenous acid decreases phosphorylation ISO RGD:732989 6480464 Arsenic Trioxide results in decreased phosphorylation of PLCG2 protein CTD PMID:20129490 benzo[a]pyrene decreases expression ISO RGD:732989 6480464 Benzo(a)pyrene metabolite results in decreased expression of PLCG2 mRNA, Benzo(a)pyrene results in decreased expression of PLCG2 mRNA CTD PMID:20064835 more ... benzo[a]pyrene affects methylation ISO RGD:732989 6480464 Benzo(a)pyrene affects the methylation of PLCG2 5' UTR, Benzo(a)pyrene affects the methylation of PLCG2 intron CTD PMID:27901495 , PMID:30157460 benzo[e]pyrene increases methylation ISO RGD:732989 6480464 benzo(e)pyrene results in increased methylation of PLCG2 exon, benzo(e)pyrene results in increased methylation of PLCG2 intron CTD PMID:30157460 bisphenol A decreases expression ISO RGD:735444 6480464 bisphenol A results in decreased expression of PLCG2 mRNA CTD PMID:26063408 bisphenol A multiple interactions ISO RGD:732989 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PLCG2 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:732989 6480464 bisphenol A results in decreased expression of PLCG2 protein CTD PMID:31675489 bisphenol A decreases methylation ISO RGD:732989 6480464 bisphenol A results in decreased methylation of PLCG2 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:732989 6480464 bisphenol A results in increased expression of PLCG2 mRNA CTD PMID:29275510 bisphenol A decreases methylation ISO RGD:735444 6480464 bisphenol A results in decreased methylation of PLCG2 promoter CTD PMID:27312807 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PLCG2 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PLCG2 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:735444 6480464 bisphenol F results in increased expression of PLCG2 mRNA CTD PMID:30951980 buta-1,3-diene decreases expression ISO RGD:735444 6480464 1, 3-butadiene results in decreased expression of PLCG2 mRNA CTD PMID:29038090 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of PLCG2 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:732989 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLCG2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:732989 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLCG2 mRNA CTD PMID:35301059 calcium atom multiple interactions ISO RGD:732989 6480464 Calcium promotes the reaction [PLCG2 protein mutant form results in increased chemical synthesis of Inositol Phosphates], Calcium promotes the reaction [PLCG2 protein results in increased chemical synthesis of Inositol Phosphates] CTD PMID:27542411 calcium(0) multiple interactions ISO RGD:732989 6480464 Calcium promotes the reaction [PLCG2 protein mutant form results in increased chemical synthesis of Inositol Phosphates], Calcium promotes the reaction [PLCG2 protein results in increased chemical synthesis of Inositol Phosphates] CTD PMID:27542411 carbon nanotube increases expression ISO RGD:735444 6480464 Nanotubes, Carbon results in increased expression of PLCG2 mRNA CTD PMID:25620056 chlorpyrifos increases methylation EXP 6480464 Chlorpyrifos results in increased methylation of PLCG2 gene CTD PMID:32905263 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of PLCG2 mRNA CTD PMID:32905263 cisplatin affects expression ISO RGD:732989 6480464 Cisplatin affects the expression of PLCG2 mRNA CTD PMID:23300844 clobetasol decreases expression ISO RGD:735444 6480464 Clobetasol results in decreased expression of PLCG2 mRNA CTD PMID:27462272 cobalt dichloride decreases expression ISO RGD:732989 6480464 cobaltous chloride results in decreased expression of PLCG2 mRNA CTD PMID:26314263 copper atom multiple interactions ISO RGD:732989 6480464 [Chelating Agents binds to Copper] which results in decreased expression of PLCG2 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:732989 6480464 [Chelating Agents binds to Copper] which results in decreased expression of PLCG2 mRNA CTD PMID:30911355 crocidolite asbestos increases expression ISO RGD:732989 6480464 Asbestos, Crocidolite results in increased expression of PLCG2 mRNA CTD PMID:23634900 , PMID:25351596 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of PLCG2 mRNA CTD PMID:26577399 dehydroepiandrosterone increases expression EXP 6480464 Dehydroepiandrosterone results in increased expression of PLCG2 mRNA CTD PMID:16940010 diarsenic trioxide decreases phosphorylation ISO RGD:732989 6480464 Arsenic Trioxide results in decreased phosphorylation of PLCG2 protein CTD PMID:20129490 dibenzo[a,l]pyrene decreases expression ISO RGD:732989 6480464 dibenzo(a, l)pyrene results in decreased expression of PLCG2 mRNA CTD PMID:31255691 dorsomorphin multiple interactions ISO RGD:732989 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLCG2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732989 6480464 Doxorubicin results in decreased expression of PLCG2 mRNA CTD PMID:30031762 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of PLCG2 mRNA CTD PMID:31464424 entinostat increases expression ISO RGD:732989 6480464 entinostat results in increased expression of PLCG2 mRNA CTD PMID:27188386 ethanol increases expression EXP 6480464 Ethanol results in increased expression of PLCG2 mRNA CTD PMID:20655511 ethanol increases expression ISO RGD:735444 6480464 Ethanol results in increased expression of PLCG2 mRNA CTD PMID:30319688 exemestane increases expression ISO RGD:732989 6480464 exemestane results in increased expression of PLCG2 mRNA CTD PMID:17254854 folic acid decreases expression ISO RGD:732989 6480464 Folic Acid results in decreased expression of PLCG2 mRNA CTD PMID:21867686 fonofos increases methylation ISO RGD:732989 6480464 Fonofos results in increased methylation of PLCG2 promoter CTD PMID:22847954 fulvestrant multiple interactions ISO RGD:732989 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PLCG2 gene CTD PMID:31601247 guanosine 5'-[gamma-thio]triphosphate multiple interactions ISO RGD:732989 6480464 [[RAC2 protein co-treated with Guanosine 5'-O-(3-Thiotriphosphate)] results in increased activity of PLCG2 protein] which results in increased chemical synthesis of Inositol Phosphates more ... CTD PMID:25903139 , PMID:27542411 Honokiol multiple interactions ISO RGD:732989 6480464 honokiol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of PLCG2 protein] CTD PMID:25980585 ibrutinib decreases response to substance ISO RGD:732989 6480464 PLCG2 protein mutant form results in decreased susceptibility to ibrutinib CTD PMID:27542411 ibrutinib multiple interactions ISO RGD:732989 6480464 (+)-JQ1 compound promotes the reaction [ibrutinib results in decreased phosphorylation of PLCG2 protein], ibrutinib promotes the reaction [(+)-JQ1 compound results in decreased phosphorylation of PLCG2 protein] CTD PMID:26254443 ibrutinib decreases phosphorylation ISO RGD:732989 6480464 ibrutinib results in decreased phosphorylation of PLCG2 protein CTD PMID:26254443 methapyrilene increases methylation ISO RGD:732989 6480464 Methapyrilene results in increased methylation of PLCG2 exon, Methapyrilene results in increased methylation of PLCG2 intron CTD PMID:30157460 methylmercury(1+) decreases expression ISO RGD:732989 6480464 methylmercury II results in decreased expression of PLCG2 mRNA CTD PMID:26314263 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:735444 6480464 Ethylnitrosourea results in increased mutagenesis of PLCG2 gene CTD PMID:16724327 N-formyl-L-methionyl-L-leucyl-L-phenylalanine multiple interactions ISO RGD:732989 6480464 AG 1879 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of PLCG2 protein], honokiol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of PLCG2 protein] CTD PMID:25980585 N-formyl-L-methionyl-L-leucyl-L-phenylalanine increases phosphorylation ISO RGD:732989 6480464 N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of PLCG2 protein CTD PMID:25980585 nickel sulfate increases expression ISO RGD:732989 6480464 nickel sulfate results in increased expression of PLCG2 mRNA CTD PMID:22714537 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of PLCG2 mRNA CTD PMID:26720608 O-methyleugenol decreases expression ISO RGD:732989 6480464 methyleugenol results in decreased expression of PLCG2 mRNA CTD PMID:32234424 ochratoxin A decreases expression ISO RGD:732989 6480464 ochratoxin A metabolite results in decreased expression of PLCG2 mRNA, ochratoxin A results in decreased expression of PLCG2 mRNA CTD PMID:26314263 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PLCG2 mRNA CTD PMID:25729387 ozone decreases expression EXP 6480464 Ozone results in decreased expression of PLCG2 mRNA CTD PMID:16330353 ozone multiple interactions ISO RGD:735444 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PLCG2 mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:735444 6480464 Acetaminophen affects the expression of PLCG2 mRNA CTD PMID:17562736 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of PLCG2 mRNA CTD PMID:17077588 paraquat affects expression EXP 6480464 Paraquat affects the expression of PLCG2 mRNA CTD PMID:18198484 parathion increases methylation ISO RGD:732989 6480464 Parathion results in increased methylation of PLCG2 promoter CTD PMID:22847954 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of PLCG2 mRNA CTD PMID:16940010 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:735444 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PLCG2 mRNA CTD PMID:23519560 pirinixic acid multiple interactions ISO RGD:732989 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLCG2 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:735444 6480464 pirinixic acid results in decreased expression of PLCG2 mRNA CTD PMID:17426115 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of PLCG2 mRNA CTD PMID:16940010 quercetin 4'-O-beta-D-glucopyranoside decreases phosphorylation ISO RGD:732989 6480464 spiraeoside results in decreased phosphorylation of PLCG2 protein CTD PMID:15613018 resveratrol multiple interactions ISO RGD:732989 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of PLCG2 mRNA, Resveratrol inhibits the reaction [COL1A1 protein results in increased phosphorylation of PLCG2 protein] CTD PMID:23557933 , PMID:26482867 SB 431542 multiple interactions ISO RGD:732989 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLCG2 mRNA CTD PMID:27188386 senecionine increases expression ISO RGD:735444 6480464 senecionine results in increased expression of PLCG2 protein CTD PMID:35357534 silicon dioxide increases expression ISO RGD:732989 6480464 Silicon Dioxide analog results in increased expression of PLCG2 mRNA CTD PMID:25895662 simvastatin increases expression ISO RGD:732989 6480464 Simvastatin results in increased expression of PLCG2 mRNA CTD PMID:17428261 sodium arsenite increases expression ISO RGD:735444 6480464 sodium arsenite results in increased expression of PLCG2 mRNA CTD PMID:36209798 sodium fluoride decreases expression ISO RGD:735444 6480464 Sodium Fluoride results in decreased expression of PLCG2 mRNA CTD PMID:21340527 starch multiple interactions EXP 6480464 Starch analog inhibits the reaction [Rapeseed Oil metabolite results in decreased expression of PLCG2 mRNA] CTD PMID:27363782 sunitinib decreases expression ISO RGD:732989 6480464 Sunitinib results in decreased expression of PLCG2 mRNA CTD PMID:31533062 terbufos increases methylation ISO RGD:732989 6480464 terbufos results in increased methylation of PLCG2 promoter CTD PMID:22847954 tetrachloromethane affects expression ISO RGD:735444 6480464 Carbon Tetrachloride affects the expression of PLCG2 mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PLCG2 mRNA CTD PMID:31150632 thapsigargin decreases expression ISO RGD:732989 6480464 Thapsigargin results in decreased expression of PLCG2 mRNA CTD PMID:29453283 thiamethoxam decreases expression ISO RGD:735444 6480464 Thiamethoxam results in decreased expression of PLCG2 mRNA CTD PMID:33533595 titanium dioxide increases expression ISO RGD:735444 6480464 titanium dioxide results in increased expression of PLCG2 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PLCG2 mRNA CTD PMID:25729387 tributylstannane decreases expression ISO RGD:732989 6480464 tributyltin results in decreased expression of PLCG2 mRNA CTD PMID:26314263 Tributyltin oxide decreases expression ISO RGD:732989 6480464 bis(tri-n-butyltin)oxide results in decreased expression of PLCG2 mRNA CTD PMID:26314263 tungsten decreases expression ISO RGD:735444 6480464 Tungsten results in decreased expression of PLCG2 mRNA CTD PMID:30912803 urethane increases expression ISO RGD:732989 6480464 Urethane results in increased expression of PLCG2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:732989 6480464 Valproic Acid affects the expression of PLCG2 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:732989 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLCG2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:732989 6480464 Valproic Acid results in increased expression of PLCG2 mRNA CTD PMID:23179753 more ... vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of PLCG2 gene CTD PMID:31079544